#Prevention

How Well Do U=U and PrEP Work? The CDC Updates Its Answers

#PrEP

#Cure

How Well Do U=U and PrEP Work? The CDC Updates Its Answers

#PrEP

#Cure

Authentic packaging for Descovy and Biktarvy

85,247 Bottles of Fake HIV Meds Worth $250M Sold in U.S., Says Gilead

Counterfeit versions of Biktarvy and Descovy were sold through pharmacies in the past two years, claims drugmaker Gilead Sciences.

“We Cannot Address Any LGBTQ Policy Agenda Without Addressing HIV”

AIDS United CEO Jesse Milan Jr. joined a White House roundtable on LGBTQ issues. He laid out three priorities.

Is My Cloth Mask Good Enough? The 2022 Edition

Public health officials are recommending that people upgrade from their cloth masks to higher-quality medical-grade masks.

“Hep ElimiNATION” to Assess and Guide U.S. Efforts to End Hepatitis

The Hep ElimiNATION partnership will assign grades to all 52 U.S. jurisdictions based on their viral hepatitis achievements.

California Requires Health Plans to Cover At-Home Tests for HIV and STIs

As sexually transmitted infections surge nationwide, a California law—the first of its kind—requires health insurance to cover home tests.

Proud Ally

Since August, Marlene McNeese has served as a member and cochair of PACHA.

MUST read

Safer Sex

Safer Injecting

Treatment-as-Prevention (TasP)

Prevention: PrEP Disparities

Disparities across states in pre-exposure prophylaxis (PrEP) use appear to have worsened over time.

Funding for Research in HIV Prevention Continues to Drop

An AVAC report also notes that most research and development of HIV prevention is funded almost entirely by one type of investor.

2021 Was a Year of HIV Progress; Now Let’s Focus on PrEP Access

Two bills in Congress will establish PrEP programs to prevent HIV. They’re needed to address racial and ethnic disparities in the epidemic.

Pre-exposure Prophylaxis (PrEP)

HIV PrEP Drug Chart

This quick reference chart compares the available options for pre-exposure prophylaxis (PrEP) for the preve...

Apretude Approved—the First Long-Acting Injectable PrEP Option

Every-other-month cabotegravir injections may work even better than daily pills for HIV prevention.

Experimental mRNA HIV Vaccine Shows Promise in Monkeys

New vaccine approach triggers neutralizing antibody production and T-cell responses and lowers risk of infection.

Like the Morning-After Pill, but for HIV

An innovative approach to postexposure prophylaxis gives people access to it before they need it.

Take This Article With You When You Request HIV PrEP

Starting today, the CDC recommends that clinicians prescribe pre-exposure prophylaxis to anyone who asks for it.

#Prevention

How Well Do U=U and PrEP Work? The CDC Updates Its Answers

#PrEP

#Cure

How Well Do U=U and PrEP Work? The CDC Updates Its Answers

#PrEP

#Cure

85,247 Bottles of Fake HIV Meds Worth $250M Sold in U.S., Says Gilead

“We Cannot Address Any LGBTQ Policy Agenda Without Addressing HIV”

Is My Cloth Mask Good Enough? The 2022 Edition

“Hep ElimiNATION” to Assess and Guide U.S. Efforts to End Hepatitis

California Requires Health Plans to Cover At-Home Tests for HIV and STIs

Proud Ally

MUST read

Safer Sex

Safer Injecting

Treatment-as-Prevention (TasP)

Prevention: PrEP Disparities

Funding for Research in HIV Prevention Continues to Drop

2021 Was a Year of HIV Progress; Now Let’s Focus on PrEP Access

Pre-exposure Prophylaxis (PrEP)

HIV PrEP Drug Chart

Apretude Approved—the First Long-Acting Injectable PrEP Option

Experimental mRNA HIV Vaccine Shows Promise in Monkeys

Like the Morning-After Pill, but for HIV

Take This Article With You When You Request HIV PrEP

POZ Poll: Do you support supervised injection sites?

Features

Opinions